Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease

Mov Disord. 2000 Jul;15(4):734-5. doi: 10.1002/1531-8257(200007)15:4<734::aid-mds1022>3.0.co;2-e.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dopamine Agents / administration & dosage
  • Dopamine Agents / adverse effects*
  • Dose-Response Relationship, Drug
  • Dyskinesia, Drug-Induced / diagnosis
  • Dyskinesia, Drug-Induced / drug therapy*
  • Female
  • GABA Agonists / administration & dosage*
  • Humans
  • Levodopa / administration & dosage
  • Levodopa / adverse effects*
  • Middle Aged
  • Parkinson Disease / drug therapy*
  • Pyridines / administration & dosage*
  • Zolpidem

Substances

  • Dopamine Agents
  • GABA Agonists
  • Pyridines
  • Levodopa
  • Zolpidem